Metraipolis › archive › dc_dbcbe9e79f43
Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy — Europe PMC PMID:42363831
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42363831
- DOI
- 10.1128/aac.00665-26
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T06:59:29.536Z
- SHA-256 of the archived text
8cd8a4a072a12588cc682cb5b9bb55b1925246d773459932299c52bab4c97a82- Stable URL of this page
https://metraipolis.com/documento/dc_dbcbe9e79f43
How to cite
Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy — Europe PMC PMID:42363831 — Europe PMC (en), https://europepmc.org/article/MED/42363831 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbcbe9e79f43 (Metraipolis archive dc_dbcbe9e79f43, sha256 8cd8a4a072a12588cc682cb5b9bb55b1925246d773459932299c52bab4c97a82)
BibTeX
@misc{dcdbcbe9e79f43,
title = {Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy — Europe PMC PMID:42363831},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42363831},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbcbe9e79f43; sha256 8cd8a4a072a12588cc682cb5b9bb55b1925246d773459932299c52bab4c97a82},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42363831. Agents can read the archived copy with the MCP tool read_document.